Ratings changes for Rigetti Computing, Micron Technology, Palantir Technologies, Applied Digital, MannKind, Humacyte, Innoviz Technologies and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
insider Jennifer Newstead sold 905 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $626.66, for a total transaction of $567,127.30. Following the completion of the transaction, the insider now owns 34,725 shares of the company’s stock, valued at $21,760,768.50. This trade represents a 2.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Affirm (NASDAQ:AFRM) was upgraded by analysts at JMP Securities from a “market perform” rating to an “outperform” rating. They now have a $78.00 price target on the stock. This represents a 22.2% upside from the current price of $63.83.
Ares Management (NYSE:ARES) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $202.00 price target on the stock, up previously from $166.00. This represents a 16.5% upside from the current price of $173.41.
Atmos Energy (NYSE:ATO) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $150.00 price target on the stock. This represents a 8.4% upside from the current price of $138.39.
BlackBerry (NYSE:BB) was upgraded by analysts at TD Securities from a “hold” rating to a “buy” rating. They now have a $4.00 price target on the stock. This represents a 14.9% upside from the current price of $3.48.
Brookline Bancorp (NASDAQ:BRKL) was upgraded by analysts at Raymond James from a “market perform” rating to a “strong-buy” rating. They now have a $16.00 price target on the stock. This represents a 35.8% upside from the current price of $11.78.
Camden National (NASDAQ:CAC) was upgraded by analysts at Raymond James from a “market perform” rating to an “outperform” rating. They now have a $50.00 price target on the stock. This represents a 15.4% upside from the current price of $43.34.
DoorDash (NASDAQ:DASH) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating.The current price is $165.76.
Brinker International (NYSE:EAT) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating. They now have a $115.00 price target on the stock, up previously from $70.00. This represents a 12.3% downside from the current price of $131.08.
Evercore (NYSE:EVR) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $339.00 price target on the stock, up previously from $269.00. This represents a 24.7% upside from the current price of $271.93.
FedEx (NYSE:FDX) was upgraded by analysts at Loop Capital from a “hold” rating to a “buy” rating. They now have a $365.00 price target on the stock, up previously from $288.00. This represents a 31.6% upside from the current price of $277.45.
FREYR Battery (NYSE:FREY) was upgraded by analysts at BTIG Research from a “neutral” rating to a “buy” rating. They now have a $4.00 price target on the stock. This represents a 85.2% upside from the current price of $2.16.
Federal Realty Investment Trust (NYSE:FRT) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $125.00 price target on the stock, up previously from $122.00. This represents a 13.2% upside from the current price of $110.46.
Innoviz Technologies (NASDAQ:INVZ) was upgraded by analysts at Rosenblatt Securities from a “neutral” rating to a “buy” rating. They now have a $4.00 price target on the stock, up previously from $3.25. This represents a 251.2% upside from the current price of $1.14.
Johnson Controls International (NYSE:JCI) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $88.00 price target on the stock. This represents a 11.1% upside from the current price of $79.24.
Kilroy Realty (NYSE:KRC) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $49.00 price target on the stock, up previously from $45.00. This represents a 21.1% upside from the current price of $40.45.
Moelis & Company (NYSE:MC) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $86.00 price target on the stock, up previously from $71.00. This represents a 18.9% upside from the current price of $72.30.
Spire (NYSE:SR) was upgraded by analysts at Mizuho from a “neutral” rating to an “outperform” rating. They now have a $76.00 price target on the stock, up previously from $65.00. This represents a 13.7% upside from the current price of $66.84.
State Street (NYSE:STT) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $95.00 price target on the stock. This represents a 1.3% downside from the current price of $96.22.
Tradeweb Markets (NASDAQ:TW) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $150.00 price target on the stock, up previously from $143.00. This represents a 14.3% upside from the current price of $131.20.
Willis Towers Watson Public (NASDAQ:WTW) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $382.00 price target on the stock, up previously from $352.00. This represents a 21.7% upside from the current price of $313.93.
Biogen (NASDAQ:BIIB) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $164.00 price target on the stock, down previously from $230.00. This represents a 11.4% upside from the current price of $147.22.
Cabaletta Bio (NASDAQ:CABA) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “inline” rating. They now have a $6.00 price target on the stock, down previously from $15.00. This represents a 152.1% upside from the current price of $2.38.
Exelixis (NASDAQ:EXEL) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $40.00 price target on the stock, up previously from $36.00. This represents a 20.2% upside from the current price of $33.27.
Halliburton (NYSE:HAL) was downgraded by analysts at Griffin Securities from a “buy” rating to a “neutral” rating.The current price is $26.06.
Hookipa Pharma (NASDAQ:HOOK) was downgraded by analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating. They now have a $2.00 price target on the stock, down previously from $48.00. This represents a 4.8% downside from the current price of $2.10.
Healthcare Realty Trust (NYSE:HR) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $19.00 price target on the stock. This represents a 12.8% upside from the current price of $16.85.
Innovative Industrial Properties (NYSE:IIPR) was downgraded by analysts at Compass Point from a “buy” rating to a “neutral” rating. They now have a $78.00 price target on the stock, down previously from $125.00. This represents a 4.6% upside from the current price of $74.55.
Kimco Realty (NYSE:KIM) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $26.00 price target on the stock. This represents a 12.3% upside from the current price of $23.16.
Lazard (NYSE:LAZ) was downgraded by analysts at Keefe, Bruyette & Woods from an “outperform” rating to a “market perform” rating. They now have a $57.00 price target on the stock, down previously from $65.00. This represents a 12.3% upside from the current price of $50.77.
Lennar (NYSE:LEN) was downgraded by analysts at BTIG Research from a “buy” rating to a “neutral” rating.The current price is $137.08.
Lineage (NASDAQ:LINE) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $75.00 price target on the stock, down previously from $78.00. This represents a 31.0% upside from the current price of $57.25.
Lamb Weston (NYSE:LW) was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $68.00 price target on the stock, down previously from $90.00. This represents a 9.6% upside from the current price of $62.03.
Merck & Co., Inc. (NYSE:MRK) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $105.00 price target on the stock, down previously from $136.00. This represents a 6.1% upside from the current price of $98.95.
NIKE (NYSE:NKE) was downgraded by analysts at Telsey Advisory Group from an “outperform” rating to a “market perform” rating. They now have a $80.00 price target on the stock, down previously from $93.00. This represents a 5.4% upside from the current price of $75.88.
Oracle (NYSE:ORCL) was downgraded by analysts at Monness Crespi & Hardt from a “neutral” rating to a “sell” rating. They now have a $130.00 price target on the stock. This represents a 22.0% downside from the current price of $166.67.
PBF Energy (NYSE:PBF) was downgraded by analysts at TD Cowen from a “hold” rating to a “sell” rating. They now have a $20.00 price target on the stock, down previously from $27.00. This represents a 20.7% downside from the current price of $25.23.
RxSight (NASDAQ:RXST) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $40.00 price target on the stock, down previously from $65.00. This represents a 15.2% upside from the current price of $34.71.
Schlumberger (NYSE:SLB) was downgraded by analysts at Griffin Securities from a “buy” rating to a “neutral” rating.The current price is $37.11.
Spero Therapeutics (NASDAQ:SPRO) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “in-line” rating. They now have a $5.00 price target on the stock. This represents a 420.8% upside from the current price of $0.96.
Montana Technologies (NASDAQ:AIRJ) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $12.00 price target on the stock. This represents a 33.5% upside from the current price of $8.99.
Applied Digital (NASDAQ:APLD) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $15.00 price target on the stock. This represents a 86.3% upside from the current price of $8.05.
Arrow Financial (NASDAQ:AROW) is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $32.00 price target on the stock. This represents a 12.8% upside from the current price of $28.37.
Atara Biotherapeutics (NASDAQ:ATRA) is now covered by analysts at Rodman & Renshaw. They set a “buy” rating and a $25.00 price target on the stock. This represents a 146.3% upside from the current price of $10.15.
Chemung Financial (NASDAQ:CHMG) is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $57.00 price target on the stock. This represents a 12.7% upside from the current price of $50.58.
California Resources (NYSE:CRC) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $63.00 price target on the stock. This represents a 24.2% upside from the current price of $50.72.
Definitive Healthcare (NASDAQ:DH) is now covered by analysts at Stephens. They set an “equal weight” rating and a $5.00 price target on the stock. This represents a 19.0% upside from the current price of $4.20.
Dianthus Therapeutics (NASDAQ:DNTH) is now covered by analysts at TD Cowen. They set a “buy” rating on the stock.The current price is $22.95.
Doximity (NASDAQ:DOCS) is now covered by analysts at Stephens. They set an “equal weight” rating and a $55.00 price target on the stock. This represents a 0.8% upside from the current price of $54.54.
Fair Isaac (NYSE:FICO) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $2,150.00 price target on the stock. This represents a 5.8% upside from the current price of $2,032.47.
Financial Institutions (NASDAQ:FISI) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $33.00 price target on the stock. This represents a 22.3% upside from the current price of $26.98.
IQVIA (NYSE:IQV) is now covered by analysts at Stephens. They set an “overweight” rating and a $250.00 price target on the stock. This represents a 27.7% upside from the current price of $195.81.
Iris Energy (NASDAQ:IREN) is now covered by analysts at BTIG Research. They set a “buy” rating and a $33.00 price target on the stock. This represents a 192.0% upside from the current price of $11.30.
LCNB (NASDAQ:LCNB) is now covered by analysts at Hovde Group. They set a “market perform” rating and a $16.25 price target on the stock. This represents a 2.5% upside from the current price of $15.86.
Liquidia (NASDAQ:LQDA) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $20.00 price target on the stock. This represents a 84.3% upside from the current price of $10.85.
Moody’s (NYSE:MCO) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $565.00 price target on the stock. This represents a 21.9% upside from the current price of $463.57.
MannKind (NASDAQ:MNKD) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $9.00 price target on the stock. This represents a 34.5% upside from the current price of $6.69.
Mind Medicine (MindMed) (NASDAQ:MNMD) is now covered by analysts at Chardan Capital. They set a “buy” rating and a $20.00 price target on the stock. This represents a 184.5% upside from the current price of $7.03.
Motorcar Parts of America (NASDAQ:MPAA) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $14.00 price target on the stock. This represents a 75.9% upside from the current price of $7.96.
Northrim BanCorp (NASDAQ:NRIM) is now covered by analysts at Hovde Group. They set an “outperform” rating and a $96.50 price target on the stock. This represents a 25.0% upside from the current price of $77.21.
OptimizeRx (NASDAQ:OPRX) is now covered by analysts at Stephens. They set an “equal weight” rating and a $5.50 price target on the stock. This represents a 12.2% upside from the current price of $4.90.
Paysign (NASDAQ:PAYS) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $6.00 price target on the stock. This represents a 103.4% upside from the current price of $2.95.
Vaxcyte (NASDAQ:PCVX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $135.00 price target on the stock. This represents a 55.2% upside from the current price of $86.96.
PennantPark Floating Rate Capital (NASDAQ:PFLT) is now covered by analysts at Raymond James. They set a “market perform” rating on the stock.The current price is $10.71.
Pagaya Technologies (NASDAQ:PGY) is now covered by analysts at UBS Group AG. They set a “neutral” rating and a $11.00 price target on the stock. This represents a 24.4% upside from the current price of $8.84.
Prothena (NASDAQ:PRTA) is now covered by analysts at Chardan Capital. They set a “buy” rating and a $40.00 price target on the stock. This represents a 158.1% upside from the current price of $15.50.
Reddit (NYSE:RDDT) is now covered by analysts at Guggenheim. They set a “buy” rating and a $210.00 price target on the stock. This represents a 29.0% upside from the current price of $162.77.
Rigetti Computing (NASDAQ:RGTI) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $12.00 price target on the stock. This represents a 43.0% upside from the current price of $8.39.
Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $72.00 price target on the stock. This represents a 129.5% upside from the current price of $31.37.
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $76.00 price target on the stock. This represents a 32.2% upside from the current price of $57.50.
S&P Global (NYSE:SPGI) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $600.00 price target on the stock. This represents a 23.3% upside from the current price of $486.67.
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Chardan Capital. They set a “buy” rating and a $24.00 price target on the stock. This represents a 113.1% upside from the current price of $11.26.
Savara (NASDAQ:SVRA) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $8.00 price target on the stock. This represents a 148.4% upside from the current price of $3.22.
Tompkins Financial (NYSEAMERICAN:TMP) is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $70.00 price target on the stock. This represents a 1.6% upside from the current price of $68.91.
Veeva Systems (NYSE:VEEV) is now covered by analysts at Stephens. They set an “overweight” rating and a $280.00 price target on the stock. This represents a 26.5% upside from the current price of $221.28.
Vital Farms (NASDAQ:VITL) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $50.00 price target on the stock. This represents a 25.1% upside from the current price of $39.96.
Valvoline (NYSE:VVV) is now covered by analysts at Stifel Nicolaus. They set a “hold” rating and a $42.00 price target on the stock. This represents a 14.7% upside from the current price of $36.63.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Apple Inc. (AAPL)
Amazon.com, Inc. (AMZN)
Alphabet Inc. (GOOGL)
Meta Platforms, Inc. (META)
Microsoft Co. (MSFT)
